SINOFERT(00297)

Search documents
中化化肥(00297.HK)中期股东应占溢利同比增5.04%至11.04亿元
Jin Rong Jie· 2025-08-25 07:50
Group 1 - The company reported a revenue of 14.715 billion RMB for the six months ending June 30, 2025, representing a year-on-year growth of 7.56% [1] - The net profit attributable to shareholders was 1.104 billion RMB, an increase of 5.04% compared to the previous year [1] - Earnings per share stood at 0.1572 RMB, with no interim dividend declared [1]
中化化肥(00297.HK):张光艳获任非执行董事

Jin Rong Jie· 2025-08-25 06:35
Core Viewpoint - Sinochem Fertilizer (00297.HK) has announced the appointment of Zhang Guangyan as a non-executive director, effective from August 25, 2025, and he will also serve as a member of the board's audit committee [1] Group 1 - Zhang Guangyan's appointment as a non-executive director is a strategic move for the company [1] - The effective date of the appointment is set for August 25, 2025 [1] - Zhang Guangyan will also take on the role of a member of the board's audit committee, indicating a focus on governance and oversight [1]
中化化肥上半年股东应占溢利增长5.04%
Zheng Quan Shi Bao Wang· 2025-08-25 06:28
Group 1 - The core viewpoint of the article is that Sinochem Fertilizer has reported its mid-term performance for the first half of 2025, showing positive growth in revenue and profit [1] Group 2 - The group's revenue for the first half of 2025 reached RMB 14.715 billion, representing a year-on-year increase of 7.56% [1] - The profit attributable to shareholders was RMB 1.104 billion, reflecting a year-on-year growth of 5.04% [1] - The basic earnings per share were reported at RMB 0.1572 [1]
港股异动 中化化肥(00297)绩后跌超6% 上半年纯利同比增超5% 不派发中期息
Jin Rong Jie· 2025-08-25 06:08
长江证券此前指出,中化化肥是中国化肥行业领军企业,资产质量优异,盈利能力强,现金流强劲,分 红率保持较高水平。未来公司钾肥进口主通道地位稳固,基础业务盈利稳定;"生物+"战略有望持续发 力,支撑公司业绩上行。预计2025-2027年归属普通股东净利润为14.6、15.5、16.3亿元,首次覆盖,给 予"买入"评级。 智通财经获悉,中化化肥(00297)绩后跌超6%,截至发稿,跌4.23%,报1.35港元,成交额1.13亿港元。 消息面上,中化化肥发布中期业绩,实现营业额人民币147.15亿元,同比增长7.56%;公司股东应占溢 利人民币11.04亿元,同比增长5.04%;每股基本盈利人民币0.1572元,不派发中期股息。公告称,营业 额增长主要系销量与平均销售价格增长所致。 本文源自:智通财经网 ...
港股异动 | 中化化肥(00297)绩后跌超6% 上半年纯利同比增超5% 不派发中期息
Zhi Tong Cai Jing· 2025-08-25 05:48
智通财经APP获悉,中化化肥(00297)绩后跌超6%,截至发稿,跌4.23%,报1.35港元,成交额1.13亿港 元。 消息面上,中化化肥发布中期业绩,实现营业额人民币147.15亿元,同比增长7.56%;公司股东应占溢 利人民币11.04亿元,同比增长5.04%;每股基本盈利人民币0.1572元,不派发中期股息。公告称,营业 额增长主要系销量与平均销售价格增长所致。 长江证券此前指出,中化化肥是中国化肥行业领军企业,资产质量优异,盈利能力强,现金流强劲,分 红率保持较高水平。未来公司钾肥进口主通道地位稳固,基础业务盈利稳定;"生物+"战略有望持续发 力,支撑公司业绩上行。预计2025-2027年归属普通股东净利润为14.6、15.5、16.3亿元,首次覆盖,给 予"买入"评级。 ...
中化化肥绩后跌超6% 上半年纯利同比增超5% 不派发中期息
Zhi Tong Cai Jing· 2025-08-25 05:44
Core Viewpoint - Sinochem Fertilizer (00297) experienced a decline of over 6% post-earnings announcement, with a current drop of 4.23% to HKD 1.35, and a trading volume of HKD 113 million [1] Financial Performance - The company reported a revenue of RMB 14.715 billion, representing a year-on-year increase of 7.56% [1] - Shareholder profit attributable to the company was RMB 1.104 billion, up 5.04% year-on-year [1] - Basic earnings per share were RMB 0.1572, with no interim dividend declared [1] Growth Drivers - Revenue growth was primarily driven by an increase in sales volume and average selling prices [1] Industry Position and Future Outlook - Changjiang Securities highlighted that Sinochem Fertilizer is a leading player in China's fertilizer industry, with excellent asset quality, strong profitability, and robust cash flow [1] - The company maintains a high dividend payout ratio, and its position as a key importer of potash fertilizer is expected to remain stable [1] - The "Bio+" strategy is anticipated to continue driving performance upward [1] - Forecasted net profit attributable to ordinary shareholders for 2025-2027 is RMB 1.46 billion, RMB 1.55 billion, and RMB 1.63 billion respectively, with an initial coverage rating of "Buy" [1]
中化化肥(00297)下跌5.63%,报1.34元/股
Jin Rong Jie· 2025-08-25 05:16
本文源自:金融界 作者:行情君 截至2024年年报,中化化肥营业总收入212.65亿元、净利润10.61亿元。 8月25日,中化化肥披露2025财年中报。 8月25日,中化化肥(00297)盘中下跌5.63%,截至13:03,报1.34元/股,成交5628.63万元。 中化化肥控股有限公司主要业务涵盖化肥资源、研发、生产、分销和农化服务全产业链,是中国化肥行 业首家在香港上市的企业,同时也是中国进口化肥的主渠道。公司拥有逾60年的化肥国际贸易经验,覆 盖了中国95%的耕地面积,磷矿资源位列国内前十,具有最齐全的大量元素、中微量元素肥料以及专用 肥、缓控释肥、生物肥等新型肥料的研发、生产能力。 ...
中化化肥公布中期业绩 股东应占溢利11.04亿元 同比增长5.04%
Zhi Tong Cai Jing· 2025-08-25 04:43
中化化肥(00297)公布2025年中期业绩,实现营业额人民币147.15亿元,同比增长7.56%;公司股东应占溢 利人民币11.04亿元,同比增长5.04%;每股基本盈利人民币0.1572元。 公告称,营业额增长主要系销量与平均销售价格增长所致。 2025年上半年,该集团依托"耕地保护国家工程研究中心"等国家级研发平台,重点推进"生物+"研发能 力建设及产品创新。在"生物+"研发能力建设方面,新建立1套生物技术研究模型,提升靶向技术研究能 力;搭建"生物+"生测体系,规范"生物+"系列产品田间和盆栽测试评价流程。在技术研究攻关方面,生 物解磷、靶向增效等3项核心生物技术达到应用阶段,并启动相关产品开发。在产品开发转化方面,集 成生物技术,发佈并上市生物肥"智养"、"焕丰",开发水溶"美麟美"及"蓝麟"升级产品并试产试销,科 研成果转化量达到101万吨,其中高端类产品转化量同比增长59%。 ...
中化化肥(00297)公布中期业绩 股东应占溢利11.04亿元 同比增长5.04%
智通财经网· 2025-08-25 04:42
公告称,营业额增长主要系销量与平均销售价格增长所致。 2025年上半年,该集团依托"耕地保护国家工程研究中心"等国家级研发平台,重点推进"生物+"研发能 力建设及产品创新。在"生物+"研发能力建设方面,新建立1套生物技术研究模型,提升靶向技术研究能 力;搭建"生物+"生测体系,规范"生物+"系列产品田间和盆栽测试评价流程。在技术研究攻关方面,生 物解磷、靶向增效等3项核心生物技术达到应用阶段,并启动相关产品开发。在产品开发转化方面,集 成生物技术,发佈并上市生物肥"智养"、"焕丰",开发水溶"美麟美"及"蓝麟"升级产品并试产试销,科 研成果转化量达到101万吨,其中高端类产品转化量同比增长59%。 智通财经APP讯,中化化肥(00297)公布2025年中期业绩,实现营业额人民币147.15亿元,同比增长 7.56%;公司股东应占溢利人民币11.04亿元,同比增长5.04%;每股基本盈利人民币0.1572元。 ...
中化化肥(00297.HK)上半年纯利增长5.04%至11.04亿元
Ge Long Hui· 2025-08-25 04:35
Core Viewpoint - Zhonghua Fertilizer (00297.HK) reported a mid-year performance for the first half of 2025, showing a steady growth in revenue and profit, driven by technological innovation and integrated operations [1] Financial Performance - The group's revenue reached RMB 14.715 billion, representing a year-on-year increase of 7.56% [1] - The profit attributable to shareholders was RMB 1.104 billion, reflecting a year-on-year growth of 5.04% [1] - Basic earnings per share were RMB 0.1572, with no dividend declared [1] Strategic Initiatives - The company emphasizes technological innovation as a key driver, leveraging an integrated research, production, and sales operation system [1] - Digital marketing strategies are being utilized to enhance market reach and precision [1] - The implementation of the "Bio+" strategy aims to improve quality and efficiency, addressing both internal and external challenges [1] Profitability Metrics - The net profit margin, calculated as profit attributable to shareholders divided by revenue, stood at 7.5%, remaining stable compared to the same period last year [1]